A dietary supplement marketer cannot base claims on human studies where the outcomes are improvement of disease symptoms or prevention of diseases. The law that is enforced by FDA dictates that a dietary supplement is not indented to diagnose, treat, … Continue reading
You may want to read this article before you start your development work.
On April 30, FDA announced via Michael Taylor, Deputy Commissioner of Foods, that the agency was starting a new review of caffeine in conventional foods. This was ostensibly triggered by the recent launch of Alert Energy gum by Wrigley. Caffeine … Continue reading
Senators Hatch and Harkin met with Commissioner Hamburg, Deputy Commissioner for Foods (Mike Taylor), and Assistant Commissioner (Jeanne Ireland) to discuss concerns and specific recommendations with respect to the Draft NDI Guidance. During the meeting, five issues were specifically raised: … Continue reading